147 related articles for article (PubMed ID: 10550417)
1. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus.
Moriwaki M; Itoh N; Miyagawa J; Yamamoto K; Imagawa A; Yamagata K; Iwahashi H; Nakajima H; Namba M; Nagata S; Hanafusa T; Matsuzawa Y
Diabetologia; 1999 Nov; 42(11):1332-40. PubMed ID: 10550417
[TBL] [Abstract][Full Text] [Related]
2. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
3. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
4. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.
Augstein P; Heinke P; Salzsieder E; Berg S; Rettig R; Salzsieder C; Harrison LC
Endocrinology; 2004 Jun; 145(6):2747-52. PubMed ID: 15033908
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy.
Iwahashi H; Itoh N; Yamagata K; Imagawa A; Nakajima H; Tomita K; Moriwaki M; Waguri M; Yamamoto K; Miyagawa J; Namba M; Hanafusa T; Matsuzawa Y
Cytokines Cell Mol Ther; 1998 Mar; 4(1):45-51. PubMed ID: 9557216
[TBL] [Abstract][Full Text] [Related]
6. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice.
Mahiou J; Walter U; Lepault F; Godeau F; Bach JF; Chatenoud L
J Autoimmun; 2001 Jun; 16(4):431-40. PubMed ID: 11437491
[TBL] [Abstract][Full Text] [Related]
7. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Redd S; Ginn S; Ross JM
Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
[TBL] [Abstract][Full Text] [Related]
8. Role of Fas-FasL in insulitis in nonobese diabetic mouse.
Cao JY; Wang H
Chin Med J (Engl); 2004 Apr; 117(4):615-7. PubMed ID: 15109461
[No Abstract] [Full Text] [Related]
9. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
Wang H; Li Y; Sun Q; Yang G
Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
[TBL] [Abstract][Full Text] [Related]
11. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
[TBL] [Abstract][Full Text] [Related]
12. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic pathology in type 1 diabetes in human.
Foulis AK
Novartis Found Symp; 2008; 292():2-13; discussion 13-8, 122-9, 202-3. PubMed ID: 19203089
[TBL] [Abstract][Full Text] [Related]
14. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
15. Death effectors of beta-cell apoptosis in type 1 diabetes.
Lee MS; Chang I; Kim S
Mol Genet Metab; 2004; 83(1-2):82-92. PubMed ID: 15464423
[TBL] [Abstract][Full Text] [Related]
16. Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice.
Suarez-Pinzon WL; Power RF; Rabinovitch A
Diabetologia; 2000 Sep; 43(9):1149-56. PubMed ID: 11043861
[TBL] [Abstract][Full Text] [Related]
17. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
Lin B; Zhang ZL; Yu LY; Guo LH
Acta Pharmacol Sin; 2003 Dec; 24(12):1199-204. PubMed ID: 14653944
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin.
Jin Y; Qu A; Wang GM; Hao J; Gao X; Xie S
Gene Ther; 2004 Jun; 11(12):982-91. PubMed ID: 15042121
[TBL] [Abstract][Full Text] [Related]
19. Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes.
Apostolou I; Hao Z; Rajewsky K; von Boehmer H
J Exp Med; 2003 Oct; 198(7):1103-6. PubMed ID: 14530378
[TBL] [Abstract][Full Text] [Related]
20. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
Hamzaoui A; Ammar J; Graïri H; Hamzaoui K
Mediators Inflamm; 2003 Aug; 12(4):209-14. PubMed ID: 14514471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
